Duke Street Bio
Last verified 2026-06-13. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $4.1Mattributed |
|---|---|
| Latest round | Funding round, $4.1M, 2026-05-15attributed |
| Founded | unknown |
| Headquarters | London |
| Industry | biotechnology |
| Stage | unknown |
| Website | dukestbio.com |
Oncology biotech developing PARP1/PARP7 inhibitor cancer therapies
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-05-15 | Funding round | $4.1M | undisclosed |
Detected tech stack
apache, apache http server, cookieyes 3.5.1, doubleclick floodlight, google analytics, google tag manager, jquery 3., jquery migrate 3.4.1, mysql, php, wordpress 7.0
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $4.1M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $4.1M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | dukestbio.com, read 2026-06-13 |
| Description | self-reported | dukestbio.com, read 2026-06-13 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $4.1M, 2026-05-15 → Funding round, $4.1M, 2026-05-15, sec-edgar, No document URL on file | Latest round | seed, $4.1M, 2026-05-15 → Funding round, $4.1M, 2026-05-15 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes